In pregnancy, levels of circulating adiponectin decrease; however, individuals who are at risk for GDM have shown markedly reduced circulating adiponectin early in gestation, and dysregulated adiponectin molecular weight distribution in the circulation [54,55]. This evidence concerns the gene ADIPOQ and gestational diabetes.